SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Blyth, Inc. (BTH), Zillow, Inc. (Z) and SinoHub, Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Blyth,
  Inc. (BTH), Zillow, Inc. (Z) and SinoHub, Inc. (SIHI) and Investigation of
                    Peregrine Pharmaceuticals, Inc. (PPHM)

PR Newswire

NEW YORK, Dec. 19, 2012

NEW YORK, Dec. 19, 2012 /PRNewswire/ --

Blyth, Inc.

Levi & Korsinsky announces that a class action lawsuit has been commenced in
the USDC for the District of Connecticut on behalf of investors who purchased
Blyth, Inc. (NYSE: BTH) stock between March 14, 2012 and November 6, 2012.

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)

For more information, click here: http://zlk.9nl.com/blyth-bth. You have
until January 12, 2013  to request that the Court appoint you as lead
plaintiff.

Zillow, Inc.

Levi & Korsinsky announces that a class action lawsuit has been commenced in
the USDC for the Western District of Washington on behalf of investors who
acquired Zillow, Inc. (Nasdaq: Z) stock between February 15, 2012 and November
6, 2012.

For more information, click here: http://zlk.9nl.com/zillow-z/. You have
until January 28, 2013  to request that the Court appoint you as lead
plaintiff.

SinoHub, Inc.

Levi & Korsinsky announces that a class action lawsuit has been commenced in
the United States District Court for the Southern District of New York on
behalf of investors who purchased SinoHub, Inc. (OTC: SIHI) stock between May
17, 2010 and August 21, 2012.

For more information, click here: http://zlk.9nl.com/sinohub-sihi/. You have
until January 21, 2013  to request that the Court appoint you as lead
plaintiff.

Peregrine Pharmaceuticals, Inc.

Levi & Korsinsky is investigating potential claims on behalf of purchasers of
Peregrine Pharmaceuticals, Inc. (NasdaqCM: PPHM) securities concerning
possible breaches of fiduciary duty in connection with the disclosure of the
discovery of major discrepancies in the treatment group of its Bavituxmab
Phase II Second-Line Non-Small Cell Lung Cancer Trial.

For more information, click here:
http://zlk.9nl.com/peregrine-pharmaceuticals-pphm/. 

Levi & Korsinsky is a national firm with offices in New York and Washington
D.C. The firm has extensive expertise in prosecuting securities litigation
involving financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. Attorney advertising. Prior results do
not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP

Website: http://www.zlk.com
 
Press spacebar to pause and continue. Press esc to stop.